SoNar-high cells were more glycolytic, enriched for higher leukemia-initiating cell (LIC) frequency, and developed leukemia much more quickly than SoNar-low counterparts in an MLL-AF9-induced murine acute myeloid leukemia (AML) model. The gene discussed is MLLT3; the disease is acute myeloid leukemia.